Reuters logo
7 months ago
BRIEF-Juniper Pharma will focus on IND-enabling activities for JNP-0201
January 6, 2017 / 1:18 PM / 7 months ago

BRIEF-Juniper Pharma will focus on IND-enabling activities for JNP-0201

1 Min Read

Jan 6 (Reuters) - Juniper Pharmaceuticals Inc

* Juniper Pharma - company will focus on IND-enabling activities for JNP-0201, including a definitive sheep study to be initiated by year-end 2017

* Juniper Pharmaceuticals Inc - an IND for JNP-0201 is also planned for first half of 2018.

* Juniper Pharmaceuticals Inc - juniper expects to conduct IND-enabling studies with JNP-0301 in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below